Unknown

Dataset Information

0

Extracellular Citrate Treatment Induces HIF1α Degradation and Inhibits the Growth of Low-Glycolytic Hepatocellular Carcinoma under Hypoxia.


ABSTRACT: HCC is well known for low glycolysis in the tumors, whereas hypoxia induces glycolytic phenotype and tumor progression. This study was conducted to evaluate the expression of SLCs in human HCCs and investigated whether extracellular nutrient administration related to SLCs in low-glycolytic HCC can prevent hypoxic tumor progression. SLCs expression was screened according to the level of glycolysis in HCCs. Then, whether extracellular nutrient treatment can affect hypoxic tumor progression, as well as the mechanisms, were evaluated in an in vitro cell line and an in vivo animal model. Low-glycolytic HCCs showed high SLC13A5/NaCT and SLC16A1/MCT1 but low SLC2A1/GLUT1 and HIF1α/HIF1α expression. Especially, high SLC13A5 expression was significantly associated with good overall survival in the Cancer Genome Atlas (TCGA) database. In HepG2 cells with the highest NaCT expression, extracellular citrate treatment upon hypoxia induced HIF1α degradation, which led to reduced glycolysis and cellular proliferation. Finally, in HepG2-animal models, the citrate-treated group showed smaller tumor with less hypoxic areas than the vehicle-treated group. In patients with HCC, SLC13A5/NaCT is an important SLC, which is associated with low glycolysis and good prognosis. Extracellular citrate treatment induced the failure of metabolic adaptation to hypoxia and tumor growth inhibition, which can be a potential therapeutic strategy in HCCs.

SUBMITTER: Kim SY 

PROVIDER: S-EPMC9315704 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Extracellular Citrate Treatment Induces HIF1α Degradation and Inhibits the Growth of Low-Glycolytic Hepatocellular Carcinoma under Hypoxia.

Kim Seon Yoo SY   Kim Dongwoo D   Kim Jisu J   Ko Hae Young HY   Kim Won Jin WJ   Park Youngjoo Y   Lee Hye Won HW   Han Dai Hoon DH   Kim Kyung Sik KS   Park Sunghyouk S   Lee Misu M   Yun Mijin M  

Cancers 20220710 14


HCC is well known for low glycolysis in the tumors, whereas hypoxia induces glycolytic phenotype and tumor progression. This study was conducted to evaluate the expression of SLCs in human HCCs and investigated whether extracellular nutrient administration related to SLCs in low-glycolytic HCC can prevent hypoxic tumor progression. SLCs expression was screened according to the level of glycolysis in HCCs. Then, whether extracellular nutrient treatment can affect hypoxic tumor progression, as wel  ...[more]

Similar Datasets

| S-EPMC9174509 | biostudies-literature
| S-EPMC10502026 | biostudies-literature
| S-EPMC10275754 | biostudies-literature
| S-EPMC7979542 | biostudies-literature
| S-EPMC10562466 | biostudies-literature
| S-EPMC7281538 | biostudies-literature
| S-EPMC10469334 | biostudies-literature
| S-EPMC4385826 | biostudies-literature
| S-EPMC8795438 | biostudies-literature
| S-EPMC11784138 | biostudies-literature